PMID- 30663168
OWN - NLM
STAT- In-Data-Review
LR  - 20190521
IS  - 1365-2893 (Electronic)
IS  - 1352-0504 (Linking)
VI  - 26
IP  - 6
DP  - 2019 Jun
TI  - Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received
      a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study.
PG  - 770-773
LID - 10.1111/jvh.13067 [doi]
AB  - This study evaluated 12-week retreatment with sofosbuvir/velpatasvir/voxilaprevir
      in patients with chronic hepatitis C virus (HCV) infection who did not achieve
      sustained virologic response after previous treatment with a sofosbuvir- and
      velpatasvir-containing regimen. All 31 patients maintained a sustained virologic 
      response 12 weeks after the last sofosbuvir/velpatasvir/voxilaprevir dose.
CI  - (c) 2019 The Authors. Journal of Viral Hepatitis Published by John Wiley & Sons
      Ltd.
FAU - Ruane, Peter
AU  - Ruane P
AUID- ORCID: https://orcid.org/0000-0002-7170-9928
AD  - Ruane Medical and Liver Health Institute, Los Angeles, California.
FAU - Strasser, Simone I
AU  - Strasser SI
AD  - AW Morrow Gastroenterology and Liver Centre, Sydney, NSW, Australia.
FAU - Gane, Edward J
AU  - Gane EJ
AD  - University of Auckland, Auckland, New Zealand.
FAU - Hyland, Robert H
AU  - Hyland RH
AD  - Gilead Sciences Inc., Foster City, California.
FAU - Shao, Jiang
AU  - Shao J
AD  - Gilead Sciences Inc., Foster City, California.
FAU - Dvory-Sobol, Hadas
AU  - Dvory-Sobol H
AD  - Gilead Sciences Inc., Foster City, California.
FAU - Tran, Tram
AU  - Tran T
AD  - Gilead Sciences Inc., Foster City, California.
FAU - Stamm, Luisa M
AU  - Stamm LM
AD  - Gilead Sciences Inc., Foster City, California.
FAU - Brainard, Diana M
AU  - Brainard DM
AD  - Gilead Sciences Inc., Foster City, California.
FAU - Nyberg, Lisa
AU  - Nyberg L
AD  - Kaiser Permanente, San Diego, California.
FAU - Shafran, Stephen
AU  - Shafran S
AD  - University of Alberta, Edmonton, AB, Canada.
LA  - eng
GR  - Gilead Sciences
PT  - Journal Article
DEP - 20190227
PL  - England
TA  - J Viral Hepat
JT  - Journal of viral hepatitis
JID - 9435672
SB  - IM
OTO - NOTNLM
OT  - direct-acting antiviral agents
OT  - hepatitis C virus
OT  - retreatment
EDAT- 2019/01/22 06:00
MHDA- 2019/01/22 06:00
CRDT- 2019/01/22 06:00
PHST- 2018/10/09 00:00 [received]
PHST- 2018/12/03 00:00 [accepted]
PHST- 2019/01/22 06:00 [pubmed]
PHST- 2019/01/22 06:00 [medline]
PHST- 2019/01/22 06:00 [entrez]
AID - 10.1111/jvh.13067 [doi]
PST - ppublish
SO  - J Viral Hepat. 2019 Jun;26(6):770-773. doi: 10.1111/jvh.13067. Epub 2019 Feb 27.